Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Mounjaro, Eli Lilly's diabetes and obesity drug, is now available in India at a fraction of its US price. It offers treatment for weight loss and diabetes control, but watch out for the side effects ...

Eli Lillys famous weight loss drug will now be sold in India after the drug maker received approval from CDSCO. What are its ...

In 1998, shortly after arriving for work, a Tennessee high-school teacher reported a "gasoline-like smell" and feeling dizzy.

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

In this week’s edition of InnovationRx, we look at the policy uncertainty around vaccines, sex differences in GLP-1 drug side ...

New Delhi, has established a dedicated committee to monitor and report adverse events related to drugs and medical devices ...

Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...

According to a report, a survey of 346 doctors revealed that 89% of them have seen a recent increase in patients requesting weight-loss medications in 2023.

Other people could be having problems with the same insulin pump, dental implant or glucose monitor that you use -- ...